TAMPA, Fla., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Advanzeon Solutions, Inc. (OTC:CHCR) ("Advanzeon") and MYnd Analytics, Inc. (NASDAQ:MYND) announced today that Advanzeon's wholly owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS"), and MYnd's wholly owned subsidiary, Arcadian Telepsychiatry Services LLC ("Arcadian"), have entered into an Agreement, expanding PVMS' and Arcadian's collaboration.  In 2015, Arcadian, through its national network of mental health professionals, served as a resource for PVMS' SleepMaster Solutions™ ("SMS") Sleep Apnea Program, providing SMS' patients with telemedicine consultation services and prescriptions for sleep apnea testing, when indicated.  This expanded collaboration is designed to leverage both companies' respective networks and capabilities, nationwide.

Rob Plotkin, CEO and Founder of Arcadian, stated, "Over the past two years, we have enjoyed a wonderful relationship with PVMS, and we look forward to expanding the scope of this collaboration, including the use of MYnd's predictive analytics and augmented intelligence platform, which helps reduce healthcare costs and improve patient outcomes. In addition to making our services available to SMS' patients, we look forward to offering the SMS Sleep Apnea Program to our patients through our nationwide network of providers. Studies show that sleep apnea is often a cause or a result of a patient's behavioral problems.  As a result, we can now offer our patients presenting with a behavioral problem various options for testing and treatment of sleep apnea.  SMS' proven program provides us with an extremely cost-effective and efficient method of doing this.  The fact that SMS takes most major insurance programs and also has affordable pricing and no-interest financing further increases our ability to expand and treat our behavioral health patient population."

Clark A. Marcus, CEO of PVMS, stated, "We are excited to expand our relationship with Arcadian.  Importantly, both our organizations provide best-in-class services and are strong believers in the future of telemedicine.  This is especially important when working with a transient population such as commercial drivers, who span all 50 states, and nationally-based referral sources, who refer their patients to us for sleep apnea testing, when indicated.  Arcadian's nationwide network is of great value to us – as is the synergistic relationship between Arcadian's area of expertise, behavioral health, and sleep apnea.  The result of this expanded relationship is anticipated to dramatically increase our resources for referrals and provide us with the ability to more efficiently, and cost effectively, handle our growing patient population without compromising medical protocols.  We expect full implementation to occur almost immediately."

About Advanzeon Solutions, Inc.
Established in 1969, Advanzeon, through its subsidiaries, owns and operates the nation's most complete sleep apnea program known as SleepMaster Solutions™ (the "Program"). Headquartered in Tampa, Florida, the Company's Program is available in all fifty states, Washington D.C. and Puerto Rico. The Program focuses on personalized attention, flexibility, a commitment to high-quality services and innovative approaches that address both the specific needs of clients and changing healthcare industry demands. For more information, visit our website at www.advanzeon.com.

About Arcadian Telepsychiatry Services LLC
Arcadian manages a suite of services including telepsychiatry, teletherapy, digital patient screening, curbside consultation, on-demand services, and scheduled encounters for all age groups.  Arcadian utilizes patient engagement and re-engagement strategies so that care is effectively completed, helping to comfortably move inpatient care to outpatient, assisting patients in readjusting to their life routine, as well as reducing wait times for mental health treatment.  Arcadian's customer base includes major health plans, health systems, and community-based organizations.

About MYnd Analytics, Inc.
MYnd Analytics, Inc. (www.myndanalytics.com) is a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients.  The Company's Psychiatric EEG Evaluation Registry, or PEER Online, is a registry and reporting platform that allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG).  Based on the Company's original physician-developed database, there are now more than 39,000 outcomes for over 11,000 unique patients in the PEER registry.  The goal of PEER Online is to provide objective, personalized data to assist physicians in the selection of appropriate medications.

Forward-Looking Statements
This press release contains forward-looking statements that are subject to risks and uncertainties. These forward-looking statements include information about possible or assumed future results of the business, financial condition, liquidity, results of operations, plans and objectives. In some cases, you may identify forward-looking statements by words such as "may," "should," "plan," "intend," "potential," "continue," "believe," "expect," "predict," "anticipate" and "estimate," the negative of these words or other comparable words. These statements are only predictions. One should not place undue reliance on these forward-looking statements. The forward-looking statements are qualified by their terms and/or important factors, many of which are outside each Company's control, involve a number of risks, uncertainties and other factors that could cause actual results and events to differ materially from the statements made.  The forward-looking statements are based on each Company's beliefs, assumptions and expectations of future performance, taking into account information currently available to each Company. Neither Company, nor any other person assumes responsibility for the accuracy or completeness of these statements. Information in this press release will be updated only to the extent required under applicable securities laws. If a change occurs, business, financial condition, liquidity and results of operations may vary materially for from those expressed in the aforementioned forward-looking statements.